[HTML][HTML] Diabetes, infection risk and COVID-19

S Erener - Molecular metabolism, 2020 - Elsevier
Background Individuals with diabetes are at a greater risk of hospitalization and mortality
resulting from viral, bacterial, and fungal infections. The coronavirus disease-2019 (COVID …

Diabetes, infection risk and COVID-19.

S Erener - Molecular Metabolism, 2020 - europepmc.org
Background Individuals with diabetes are at a greater risk of hospitalization and mortality
resulting from viral, bacterial, and fungal infections. The coronavirus disease-2019 (COVID …

Diabetes, infection risk and COVID-19

S Erener - Molecular metabolism, 2020 - pubmed.ncbi.nlm.nih.gov
Background Individuals with diabetes are at a greater risk of hospitalization and mortality
resulting from viral, bacterial, and fungal infections. The coronavirus disease-2019 (COVID …

[引用][C] Diabetes, infection risk and COVID-19

S Erener - Molecular Metabolism, 2020 - cir.nii.ac.jp
Diabetes, infection risk and COVID-19 | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …

[HTML][HTML] Diabetes, infection risk and COVID-19

S Erener - Molecular Metabolism, 2020 - ncbi.nlm.nih.gov
Background Individuals with diabetes are at a greater risk of hospitalization and mortality
resulting from viral, bacterial, and fungal infections. The coronavirus disease-2019 (COVID …

Diabetes, infection risk and COVID-19

S Erener - Molecular metabolism, 2020 - pubmed.ncbi.nlm.nih.gov
Background Individuals with diabetes are at a greater risk of hospitalization and mortality
resulting from viral, bacterial, and fungal infections. The coronavirus disease-2019 (COVID …

Diabetes, infection risk and COVID-19.

S Erener - Molecular Metabolism, 2020 - europepmc.org
Background Individuals with diabetes are at a greater risk of hospitalization and mortality
resulting from viral, bacterial, and fungal infections. The coronavirus disease-2019 (COVID …